Larimar Therapeutics LRMR
NASDAQ LRMR
$2.73 +0.04 (+1.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Larimar Therapeutics (LRMR) Gains (Losses) on Sale of Assets & Investments (2015 - 2026)

Updated

Larimar Therapeutics (LRMR) recorded Non Operating Investment Income of -$4,000 in Q1 2015.

Analysis

Larimar Therapeutics (LRMR) Gains (Losses) on Sale of Assets & Investments (2015 - 2026) Analysis & Trends

For FY2014, Larimar Therapeutics reported Non Operating Investment Income of -$35,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Larimar Therapeutics 279.45 Mn -389.49 Mn - -18,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18,000.00
Mar 31, 2026 -48,000.00
Dec 31, 2025 -12,000.00
Sep 30, 2025 75,000.00
Jun 30, 2025 -63,000.00
Mar 31, 2025 -94,000.00
Dec 31, 2024 -210,000.00
Sep 30, 2024 508,000.00
Jun 30, 2024 -125,000.00
Mar 31, 2024 -106,000.00
Dec 31, 2023 74,000.00
Sep 30, 2023 -5,000.00
Jun 30, 2023 12,000.00
Mar 31, 2023 31,000.00
Dec 31, 2022 9,000.00
Sep 30, 2022 17,000.00
Jun 30, 2022 -57,000.00
Sep 30, 2021 -1,000.00
Dec 31, 2020 3,000.00
Sep 30, 2020 1,000.00
API Access

Larimar Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LRMR&period=max&api_key=YOUR_API_KEY